The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Defense
Grant: PR180747
National Institutes of Health
Grant: R01 NS075012
NCRR NIH HHS
Grant: UL1 RR024128
Intramural NIH HHS
Grant: ZIA TR000106
National Institutes of Health
Grant: 3R01NS075012-01A1S1
Non-invasive Markers of Neurodegeneration in Movement Disorders
National Institutes of Health
Grant: 3UL1RR024128-04S5
DUKE CTSI: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA)
Tyler’s Hope for a Dystonia Cure Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals